
Amble Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: flat-price compounded GLP-1 with free shipping and discounts for 3- or 6-month plans
Amble scores highest on state availability and ease of access.
Semaglutide
then $179/mo ongoing
Tirzepatide
then $329/mo ongoing
Price checked on Amble’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Amble is an Ohio-based telehealth platform that connects patients with licensed physicians for compounded semaglutide and tirzepatide at the same price at every dose, with medication, supplies, and shipping included. Month to month, semaglutide is $179 and tirzepatide $329, with $50 off the first month; 3- and 6-month plans paid upfront lower that to as little as $135 and $235 a month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Amble?
Amble is an online platform from Amble Health, Inc. that connects you with state-licensed physicians who can prescribe compounded GLP-1 injections, with the same price at every dose. Plans include medication, supplies, shipping, and 24/7 messaging with your provider, and longer plans cost less per month. It suits people who want a flat, predictable price and are comfortable committing to a multi-month plan.
Vetted alternatives to Amble
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Amble at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo (after intro offer) ($129 first month)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Amble
Each dimension is scored algorithmically from Amble’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $179/mo (after intro offer), Amble runs in line with the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $129. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Amble offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.5/10Online intake and platform experience (ongoing clinician messaging, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.4/10Amble treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
6.1/10Clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Amble review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $179–$329/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Amble
We walked Amble’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1The GLP-1 product page shows a plan picker with per-month prices for 1-, 3- and 6-month plans before you start
- 2'Get started' opens Amble's intake, labeled as an 11-step questionnaire
- 3Step 1 asks 'Have you taken a GLP-1 medication before?'
- Semaglutide and tirzepatide each have their own price table (semaglutide $179 month to month, tirzepatide $329), and a '$50 off first month' banner says the discount is auto-applied at checkout
- The Terms say multi-month plans are charged upfront and can't be refunded once sent to the pharmacy, which the product pages don't mention
- The FAQ says a video or audio visit is required only in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi
- The homepage advertises 'Plans starting at $99 per month,' which doesn't match any GLP-1 plan shown
Amble customer support
- hello@joinamble.com
GLP-1 medications Amble offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$50 off first month, auto-applied at checkout. Longer plans, charged upfront: 3-month $160/mo, 6-month $135/mo. The site's mobile price table lists 6-month at $145/mo and adds a 12-month plan at $135/mo.
$50 off first month, auto-applied at checkout. Longer plans, charged upfront: 3-month $255/mo, 6-month $235/mo.
Ready to get started?
Plans and promotions change often, so check Amble's current pricing and active discounts before you decide.
What we like
- Same price at every dose, with medication, supplies, and shipping included
- $50 off your first month, applied automatically at checkout
- 3- and 6-month plans lower the monthly price (semaglutide as low as $135/mo, tirzepatide $235/mo)
- Refund of your initial payment if a provider decides treatment isn't medically appropriate
- Displays a LegitScript seal that links to its certification record
- 4.5 stars from about 4,600 Trustpilot reviews
- Unlimited 24/7 support included
Watch-outs
- Longer plans are a firm commitment charged upfront, and no part is refundable once sent to the pharmacy
- To stop a renewal, you must cancel at least 15 days before your next billing date
- The homepage says 'Plans starting at $99 per month,' but no GLP-1 plan we found costs $99
- Tirzepatide is pricey month to month at $329
- Doesn't name its pharmacy partners or prescribing physicians
- A short video or audio visit is required in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi
- Strict billing terms: the Terms warn that customers who dispute charges may be sent to collections
Amble's pitch: one flat price that never climbs as your dose does
Amble is a straightforward, mainstream telehealth route to compounded GLP-1 medication, and its single most useful idea is right there in its own marketing: "same price, every dose." Most compounding programs quietly raise your bill as you titrate up to a higher milligram strength. Amble doesn't. Month to month, you pay $179 a month (after intro offer) for compounded semaglutide, starter dose or full maintenance dose alike, and that predictability is the main reason to consider it. If you've been burned by a program where month four cost noticeably more than month one, this is the antidote.
Is it worth it? For someone who wants no-drama online access to a GLP-1 without doing a lot of homework, often yes. Amble is deliberately simple. The flip side is that it's light on some public details and strict on billing, so read the Terms before you pick a longer plan.
How the pricing works
Amble uses flat, all-inclusive pricing rather than the dose-tiered ladders you'll see elsewhere. Compounded semaglutide is $179 a month (after intro offer) on a month-to-month plan, with $50 off your first month applied automatically at checkout, bringing month one to $129. Compounded tirzepatide, the dual-action molecule behind Mounjaro and Zepbound, is $329 a month month to month, or $279 for the first month with the same discount. For context, the median cheapest ongoing rate across the GLP-1 providers we track is about $179, so month-to-month semaglutide through Amble runs a touch above the middle of the pack, while tirzepatide at that price is on the expensive side.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
Longer plans cut the rate: 3- and 6-month plans bring semaglutide down to as little as $135 a month and tirzepatide to $235 a month. But the Terms say those plans are "a firm commitment to the full duration of the program," charged in full at purchase, and no part is refundable once the order is sent to the pharmacy. HSA and FSA cards are accepted on 3-month or longer plans. Also ignore the homepage line about plans "starting at $99 per month"; we found no GLP-1 plan at $99. Compare Bodi Envi, which also charges one price at every dose and says there are no long-term contracts.
The number that matters is what's bundled into it. Amble states that medication, supplies, and shipping are all included, plus the clinician consult, with no separate membership on top of the drug. Harmon.Health bundles the same pieces, with the visit, medication, supplies and free shipping in one monthly price. That helps when you compare quotes: a lower sticker price elsewhere can hide a separate consult fee, a shipping charge, or a supplies upcharge that Amble folds into the one figure.
- Flat by design: the same monthly price holds as you titrate to higher doses
- Bundled: medication, supplies, and shipping included in the quoted price
- First-month discount: $50 off month one, auto-applied at checkout
- Fine print to know: cancel renewals at least 15 days before your next billing date, or the cancellation may roll to the following cycle
The medications and how you get them
Amble offers both of the heavyweight GLP-1 options: semaglutide and tirzepatide. Having both under one roof matters because they're not interchangeable. Tirzepatide hits a second hormone receptor and tends to drive larger losses in trials, while semaglutide is the more established, lower-cost starting point. You can start on one and switch within the same program without re-onboarding somewhere new.
The process is fully online: an 11-step intake questionnaire, review by a licensed clinician, and a compounded GLP-1 shipped to your door with the supplies you need to inject. Most states need no live visit, but the FAQ says a short video or audio visit is required in New Mexico, Kansas, West Virginia, Louisiana, and Mississippi. Unlimited 24/7 support is included.
What you're buying, and what to ask
Amble's medications are compounded, not the FDA-approved brand-name pens. Compounded GLP-1s are mixed by a pharmacy rather than manufactured by Lilly or Novo Nordisk, which is how the price stays low, but it also means the specific pharmacy and its sourcing matter. Amble displays a LegitScript seal that links to its certification record, and there are no FDA warning letters on file. It does not, however, name its pharmacy partners or prescribing physicians publicly.
So before you commit, ask Amble directly which compounding pharmacy fills your prescription and whether it's a state-licensed 503A or a 503B outsourcing facility.
Who should choose Amble, and who should skip it
Amble is a strong fit if you want both major GLP-1 options, value a price that won't creep upward as you increase your dose, and want a provider with a solid public track record: it holds 4.5 stars from about 4,600 Trustpilot reviews. It advertises availability in all 50 states, though it says exclusions apply without listing them, so confirm your state during intake. It's also a good pick for people who find most telehealth checkouts confusing and just want one number that covers everything. Another provider to compare is Genesis Health, which pairs its flat-priced compounded semaglutide and tirzepatide with health coaching and a member community, though it was named in a February 2026 FDA warning letter.
Skip it if you specifically need brand-name Wegovy, Ozempic, Mounjaro, or Zepbound; Amble's lane is compounded, and there's no brand-name pricing on file. Skip the longer plans if you might stop early, since they are non-refundable once the pharmacy has the order, and note that the Terms warn customers who dispute charges for orders already sent to the pharmacy may be sent to collections. Detail-oriented patients who want the exact compounding partner spelled out up front will find Amble's public information thinner than they'd like.
Bottom line
Amble does one thing unusually well: it removes dose-based pricing anxiety from a GLP-1 program. A flat, all-inclusive $179 a month (after intro offer) for compounded semaglutide that doesn't rise with your dose, both molecules available, and broad reach make it a sensible mainstream option. Just go in clear-eyed about the strict prepay and cancellation terms, and confirm the compounding pharmacy before your first shipment. Compare it against the field using our scoring methodology, and if simple, predictable pricing is what you're after, Amble is built around it.
The Bottom Line
Amble scores highest on state availability and ease of access.
Ready to start with Amble?
From $179/mo (after intro offer). See current pricing and start your free consultation.
Amble might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Amble vs…
Amble scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Amble vs Amazon One Medical
Amazon One Medical scores 8.5/10

Amble vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Amble review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Amble's current pricing
Plans from $179/mo (after intro offer). Start your free consultation to check eligibility and today's price.